Jennifer Litton, MD, on Defining Endpoints for Neoadjuvant Breast Cancer Trials
The recent update to the Standardized Definitions for Efficacy End Points (STEEP) criteria for adjuvant breast cancer (BC) trials included some separately defined endpoints for neoadjuvant trials.